Overview

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

Status:
NOT_YET_RECRUITING
Trial end date:
2029-12-30
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized controlled, prospective clinical study.
Phase:
PHASE2
Details
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Treatments:
130-nm albumin-bound paclitaxel
Albumin-Bound Paclitaxel
Chemoradiotherapy
Cisplatin
Surgical Procedures, Operative